, , Ahmed, K., Baeten, J. M., Beksinska, M., Bekker, L., Bukusi, E. A., Donnell, D., Gichangi, P. B., Heller, K. B., Hofmeyr, G. J., Justman, J., Kasaro, M. P., Kiarie, J., Louw, C., Mastro, T. D., Morrison, C. S., Mugo, N. R., Nair, G., Nanda, K., Nhlabatsi, Z., Onono, M., Palanee-Phillips, T., Pleaner, M., Rees, H., Singata-Madliki, M., Scoville, C. W., Selepe, R. A. P., Shears, K., Sibiya, S., Smit, J., Steyn, P. S., Stringer, J., Taylor, D., Thomas, K. K., & Welch, J. D. (2019). hIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet, 394(10195), 303–313. http://access.bl.uk/ark:/81055/vdc_100088833663.0x000060